Skip to Content

COVID-19 Info: Please help us slow the spread of coronavirus - Wear a Mask, Wash Your Hands & Wait 6 Feet Apart!
Visitor Policies and Precautions | COVID-19 Testing| Vaccine information | Commitment to Safety | Current Numbers

Clinical Trials Search Results

Showing 1-10 of 23

Sorted By:

  • A081105

    Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

  • AFT 25 Comet

    Comparison Of Operative To Monitoring And Endocrine Therapy (Comet) Trial For Low Risk Dcis: A Phase Iii Prospective Randomized Trial

  • Alliance A011401

    Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer.

  • Alliance A011502

    A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer.

  • Alliance A021502 (Atomic)

    Testing the addition of the antibody atezolizumab to usual chemotherapy after surgery in patients with colon cancer

  • Alliance A151216

    Genetic Testing For Patients with Resectable or Resected Lung Cancer

  • Alliance A211601

    Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502

  • CCCWFU 97116

    A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment

  • CCCWFU 97415 (Upbeat)

    Understanding and Predicting Breast Cancer Events after Treatment (UPBEAT).

  • CTSU EA5142

    Nivolumab after Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer